BIEST TD 50/50 — Class II drug recall D-0188-2016
Terminated recall by the Compounder, reported 2015-11-18, distributed nationwide. Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross
| Recall number | D-0188-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | the Compounder, Aurora, IL, United States |
| Recall initiated | 2015-03-10 |
| Classified | 2015-11-10 |
| Reported by FDA | 2015-11-18 |
| Terminated | 2016-05-19 |
| Distributed | Nationwide (US) |
| Quantity | 5 |
| Expiration dates | 2015-06-21 |
Product
BIEST TD 50/50 (Estradiol USP Micronized (E2)/Estriol USP Micronized (E3)) W/V (weight /volume) 4.0 MG/ML transdermal cream packaged in 3mL syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.
Reason for recall
Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0188-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.